©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 109614
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.109614
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.109614
Table 2 Comparison of the OraQuick hepatitis C virus self-test and other point-of-care tests
| Test | Type | Sample | Target | Sensitivity | Specificity | Time | Setting |
| OraQuick HCV self-test | Rapid Ab | Oral fluid | Anti-HCV Ab | 97.8% | 100% | 20 min | Self-test |
| Alere Truline HCV rapid test | Rapid Ab | Fingerstick blood | Anti-HCV Ab | 99.4% | 99.7% | 15–20 min | Clinic/POC |
| SD Bioline HCV test | Rapid Ab | Fingerstick blood | Anti-HCV Ab | 99.4% | 99.7% | 15–20 min | Clinic/POC |
| GeneXpert HCV Viral Load | NAAT (RT-PCR) | Plasma/serum | HCV RNA | 100% | 98.5% | Approximately 105 min | Decentralized POC |
| Lab-based HCV ELISA | ELISA | Serum/plasma | Anti-HCV Ab | ≥ 99% | ≥ 99% | Hours/days | Central lab |
| Lab-based HCV RNA (PCR) | RT-PCR (quantitative) | Plasma/serum | HCV RNA | Reference standard | Reference standard | Hours–days | Central lab |
- Citation: Saifullah M, Khan M, Usman MA, Mehmood Q, Mehdi AM. OraQuick hepatitis C virus self-test: A new frontier in hepatitis C screening. World J Virol 2025; 14(3): 109614
- URL: https://www.wjgnet.com/2220-3249/full/v14/i3/109614.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i3.109614